Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10316/95895
Título: | Re-Use of Caco-2 Monolayers in Permeability Assays—Validation Regarding Cell Monolayer Integrity | Autor: | Pires, Cristiana L. Praça, Catarina Martins, Patrícia A. T. Batista de Carvalho, Ana L. M. Ferreira, Lino Catarro, Maria Paula M. Marques Moreno, Maria João |
Palavras-chave: | Caco-2 cells; High-throughput; Intestinal permeability; Lucifer yellow; Tight junctions | Data: | 2021 | Editora: | MDPI | Projeto: | UIDB/00070/2020 NEUROATLANTIC/EAPA_791/2018 0624_2IQBIONEURO_6_E SFRH/BD/138873/2018 UIDB/00313/2020 UIDP/00313/2020 PT2020-PTDC/QUI-OUT/29373/2017 PT2020-PTDC/DTP-FTO/2784/2014 |
Título da revista, periódico, livro ou evento: | Pharmaceutics | Volume: | 13 | Número: | 10 | Resumo: | Caco-2 monolayers are a common in vitro model used to evaluate human intestinal absorption. The reference protocol requires 21 days post-seeding to establish a stable and confluent cell monolayer, which is used in a single permeability assay during the period of monolayer stability (up to day 30). In this work, we characterize variations in the tightness of the cell monolayer over the stable time interval and evaluate the conditions required for their re-use in permeability assays. The monolayer integrity was assessed through TEER measurements and permeability of the paracellular marker Lucifer Yellow (LY), complemented with nuclei and ZO-1 staining for morphological studies and the presence of tight junctions. Over 150 permeability assays were performed, which showed that manipulation of the cell monolayer in the permeability assay may contribute significantly to the flux of LY, leading to Papp values that are dependent on the sampling duration. The assay also leads to a small decrease in the cell monolayer TEER, which is fully recovered when cell monolayers are incubated with culture media for two full days. When this procedure is followed, the cell monolayers may be used for permeability assays on days 22, 25, and 28, triplicating the throughput of this important assay. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. | URI: | https://hdl.handle.net/10316/95895 | ISSN: | 1999-4923 | DOI: | 10.3390/pharmaceutics13101563 | Direitos: | openAccess |
Aparece nas coleções: | I&D CQC - Artigos em Revistas Internacionais I&D CNC - Artigos em Revistas Internacionais I&D QFM-UC - Artigos em Revistas Internacionais FMUC Medicina - Artigos em Revistas Internacionais FCTUC Ciências da Vida - Artigos em Revistas Internacionais |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
pharmaceutics-13-01563-v2.pdf | 4.4 MB | Adobe PDF | Ver/Abrir |
Citações SCOPUSTM
26
Visto em 30/set/2024
Citações WEB OF SCIENCETM
27
Visto em 2/out/2024
Visualizações de página
322
Visto em 1/out/2024
Downloads
226
Visto em 1/out/2024
Google ScholarTM
Verificar
Altmetric
Altmetric
Este registo está protegido por Licença Creative Commons